Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 6, 2013, Pages 1130-1137

  Abeles, Shira R ^a   Chuquiyauri, Raul ^a,b   Tong, Carlos ^c   Vinetz, Joseph M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANOPHELES; ANOPHELES DARLINGI; ARTICLE; BLOOD; CLINICAL ASSESSMENT; CYTOKINE RESPONSE; DISEASE TRANSMISSION; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OOCYST; PERU; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA;

ADOLESCENT; ADULT; ANIMALS; ANOPHELES; CYTOKINES; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; INSECT VECTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALARIA; MALARIA, VIVAX; MALE; MIDDLE AGED; PARASITEMIA; PERU; PLASMODIUM VIVAX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

ANOPHELES DARLINGI; PLASMODIUM VIVAX;

EID: 84878777505     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0752     Document Type: Article

References (36)

1. Sattabongkot J, Maneechai N, Phunkitchar V, Eikarat N, Khuntirat B, Sirichaisinthop J, Burge R, Coleman RE, 2003. Comparison of artificial membrane feeding with direct skin feeding to estimate the infectiousness of Plasmodium vivax gametocyte carriers to mosquitoes. Am J Trop Med Hyg 69: 529 -535.
2. Bharti AR, Chuquiyauri R, Brouwer KC, Stancil J, Lin J, Llanos-Cuentas A, Vinetz JM, 2006. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon. Am J Trop Med Hyg 75: 610-616. (Pubitemid 46941263)
3. Toure YT, Doumbo O, Toure A, Bagayoko M, Diallo M, Dolo A, Vernick KD, Keister DB, Muratova O, Kaslow DC, 1998. Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine site. Am J Trop Med Hyg 59: 481-486. (Pubitemid 28429095)
4. Graves PM, Burkot TR, Carter R, Cattani JA, Lagog M, Parker J, Brabin BJ, Gibson FD, Bradley DJ, Alpers MP, 1988. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology 96: 251-263.
5. Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN, 1992. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunol 14: 385-396.
6. Roeffen W, Geeraedts F, Eling W, Beckers P, Wizel B, Kumar N, Lensen T, Sauerwein R, 1995. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun 63: 467-471.
7. Drakeley CJ, Bousema JT, Akim NI, Teelen K, Roeffen W, Lensen AH, Bolmer M, Eling W, Sauerwein RW, 2006. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol 28: 185-190.
8. Hisaeda H, Stowers AW, Tsuboi T, Collins WE, Sattabongkot JS, Suwanabun N, Torii M, Kaslow DC, 2000. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun 68: 6618-6623. (Pubitemid 32463362)
9. Arevalo-Herrera M, Solarte Y, Rocha L, Alvarez D, Beier JC, Herrera S, 2011. Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast. Am J Trop Med Hyg 84: 71-77.
10. Mendis KN, Naotunne TD, Karunaweera ND, Del Giudice G, Grau GE, Carter R, 1990. Anti-parasite effects of cytokines in malaria. Immunol Lett 25: 217-220. (Pubitemid 20260872)
11. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, King E, Andrews L, Bejon P, Gilbert SC, De Souza JB, Sinden R, Hill AV, Riley EM, 2006. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol 177: 5736 -5745.
12. Zeyrek FY, Kurcer MA, Zeyrek D, Simsek Z, 2006. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunol 28: 201-207.
13. Yeom JS, Park SH, Ryu SH, Park HK, Woo SY, Ha EH, Lee BE, Yoo K, Lee JH, Kim KH, Kim S, Kim YA, Ahn SY, Oh S, Park HJ, Min GS, Seoh JY, Park JW, 2003. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hepatic dysfunction. Trans R Soc Trop Med Hyg 97: 687-691. (Pubitemid 41051079)
14. Park JW, Park SH, Yeom JS, Huh AJ, Cho YK, Ahn JY, Min GS, Song GY, Kim YA, Ahn SY, Woo SY, Lee BE, Ha EH, Han HS, Yoo K, Seoh JY, 2003. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without thrombocytopenia. Ann Trop Med Parasitol 97: 339-344. (Pubitemid 36754259)
15. Seoh JY, Khan M, Park SH, Park HK, Shin MH, Ha EH, Lee BE, Yoo K, Han HS, Oh S, Wi JH, Hong CK, Oh CH, Kim YA, Park JW, 2003. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hyperpyrexia. Am J Trop Med Hyg 68: 102-106. (Pubitemid 38234856)
16. Jain V, Singh PP, Silawat N, Patel R, Saxena A, Bharti PK, Shukla M, Biswas S, Singh N, 2010. A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India. Acta Trop 113: 263 -268.
17. Long GH, Chan BH, Allen JE, Read AF, Graham AL, 2008. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. Int J Parasitol 38: 1073-1081.
18. Luckhart S, Crampton AL, Zamora R, Lieber MJ, Dos Santos PC, Peterson TM, Emmith N, Lim J, Wink DA, Vodovotz Y, 2003. Mammalian transforming growth factor beta1 activated after ingestion by Anopheles stephensi modulates mosquito immunity. Infect Immun 71: 3000-3009. (Pubitemid 36637520)
19. Luckhart S, Lieber MJ, Singh N, Zamora R, Vodovotz Y, 2008. Low levels of mammalian TGF-beta1 are protective against malaria parasite infection, a paradox clarified in the mosquito host. Exp Parasitol 118: 290-296.
20. Long GH, Chan BH, Allen JE, Read AF, Graham AL, 2008. Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evol Biol 8: 128.
21. Naotunne TS, Karunaweera ND, Mendis KN, Carter R, 1993. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 78: 555-562. (Pubitemid 23114231)
22. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637. (Pubitemid 39303671)
23. Mirghani HA, Eltahir HG, A-Elgadir TM, Mirghani YA, Elbashir MI, Adam I, 2010. Cytokine profiles in children with severe Plasmodium falciparum malaria in an area of unstable malaria transmission in Central Sudan. J Trop Pediatr 57: 392-395
24. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarencio J, Camargo LM, Barral A, Barral-Netto M, 2010. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 9: 13.
25. Kilian AH, Metzger WG, Mutschelknauss EJ, Kabagambe G, Langi P, Korte R, von Sonnenburg F, 2000. Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health 5: 3-8. (Pubitemid 30108296)
26. Bowers KM, Bell D, Chiodini PL, Barnwell J, Incardona S, Yen S, Luchavez J, Watt H, 2009. Inter-rater reliability of malaria parasite counts and comparison of methods. Malar J 8: 267.
27. O'Meara WP, McKenzie FE, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C, 2005. Sources of variability in determining malaria parasite density by microscopy. Am J Trop Med Hyg 73: 593-598. (Pubitemid 41324267)
28. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, Banchereau J, 1994. High levels of circulating IL-10 in human malaria. Clin Exp Immunol 95: 300-303. (Pubitemid 24207143)
29. Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, Behr C, Akanmori BD, 2006. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J Infect Dis 194: 1438-1446. (Pubitemid 44706513)
30. Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KN, 1992. Tumour necrosis factordependent parasite-killing effects during paroxysms in nonimmune Plasmodium vivax malaria patients. Clin Exp Immunol 88: 499-505.
31. Naotunne TS, Karunaweera ND, Del Giudice G, Kularatne MU, Grau GE, Carter R, Mendis KN, 1991. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J Exp Med 173: 523-529.
32. Niikura M, Inoue S, Kobayashi F, 2011. Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J Biomed Biotechnol 2011: 383962.
33. Gazzinelli RT, Oswald IP, James SL, Sher A, 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gammaactivated macrophages. J Immunol 148: 1792-1796.
34. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG, 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 175: 169-174.
35. Kobayashi F, Ishida H, Matsui T, Tsuji M, 2000. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. J Vet Med Sci 62: 583-587.
36. Angulo I, Fresno M, 2002. Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol 9: 1145-1152. (Pubitemid 35283273)